Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases
A targeted mass spectrometric assay was developed for identification and quantification of apoE isoforms (apoE2, E3 and E4), and it was utilized for screening of samples from AD patients (n = 39) and patients with other neurodegenerative disorders (n = 38). The assay showed good linearity with LOQ c...
Main Authors: | Melinda Rezeli, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, Thomas Laurell, Oskar Hansson, György Marko-Varga |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-09-01
|
Series: | EuPA Open Proteomics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212968515300143 |
Similar Items
-
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
by: Elles Konijnenberg, et al.
Published: (2020-05-01) -
Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
by: K. Minta, et al.
Published: (2020-02-01) -
Association between high molecular weight apolipoprotein isoforms and lipoprotein levels in advanced chronic kidney disease and the effect of hemodialysis
by: J K Gambhir, et al.
Published: (2013-01-01) -
Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer
by: Yu Sato, et al.
Published: (2020-09-01) -
Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
by: Mehrabian S, et al.
Published: (2015-12-01)